Underwriting and Claims
  • Videos
  • April 2022
  • 32 minutes

Long COVID-19: Where are all the claims?

By
  • Dr. John J. Lefebre
In Brief

Curious about RGA's medical insights?  Contact us to learn more. 

Two years into the pandemic, more than 300 million people have been infected, with 2.3% to 37% of COVID-19 survivors reporting ongoing symptoms consistent with a diagnosis of long COVID-19.  

Yet from an insurance standpoint we are not seeing a tsunami of long COVID claims. Why is this?

Dr. John Lefebre, Vice President and Senior Medical Director for RGA, discusses some possible explanations and takes a further look at the medical issues that may affect COVID-19 survivors and impact underwriting and claims adjudication.

At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.  




More Like This...

  • Articles
    March 2021
    Long-Term Disability in the Time of COVID-19: The Economic Impact of the First "Pandemic Recession"
    Read More
  • Publications
    November 2021
    Coverage over the Long-Haul: Managing Disability Claims for long COVID
    Read More
  • Publications
    January 2022
    Claims and COVID-19: RGA Global Survey Sheds Light on Short-Term Challenges and Longer Lasting Risks
    Read More
  • Videos
    June 2021
    Long COVID: Insurance Underwriting Perspectives
    Read More
  • Publications
    February 2021
    Global Claims Views: After the Storm, Long-Term Health Consequences of COVID-19
    Read More
  • View All RGA Articles

Related Solutions

Meet the Authors & Experts

Expert
Dr. John J. Lefebre
Vice President and Senior Global Medical Director, Global Medical